ATE298887T1 - Verfahren zum nachweis solider krebszellen und histologischer heterotypien und verfahren zur prüfung von gewebe für die knochenmarktransplantation und die transplantation von peripheren blutstammzellen - Google Patents
Verfahren zum nachweis solider krebszellen und histologischer heterotypien und verfahren zur prüfung von gewebe für die knochenmarktransplantation und die transplantation von peripheren blutstammzellenInfo
- Publication number
- ATE298887T1 ATE298887T1 AT97915725T AT97915725T ATE298887T1 AT E298887 T1 ATE298887 T1 AT E298887T1 AT 97915725 T AT97915725 T AT 97915725T AT 97915725 T AT97915725 T AT 97915725T AT E298887 T1 ATE298887 T1 AT E298887T1
- Authority
- AT
- Austria
- Prior art keywords
- tissue
- cancer cells
- solid cancer
- bone marrow
- peripheral blood
- Prior art date
Links
Classifications
-
- G—PHYSICS
- G01—MEASURING; TESTING
- G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
- G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
- G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
- G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
-
- G—PHYSICS
- G01—MEASURING; TESTING
- G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
- G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
- G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
- G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
- G01N33/53—Immunoassay; Biospecific binding assay; Materials therefor
- G01N33/575—Immunoassay; Biospecific binding assay; Materials therefor for cancer
- G01N33/5758—Immunoassay; Biospecific binding assay; Materials therefor for cancer involving compounds serving as markers for tumours, cancers or neoplasias, e.g. cellular determinants, receptors, heat shock/stress proteins, A-protein, oligosaccharides or metabolites
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12Q—MEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
- C12Q1/00—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions
- C12Q1/68—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions involving nucleic acids
- C12Q1/6876—Nucleic acid products used in the analysis of nucleic acids, e.g. primers or probes
- C12Q1/6883—Nucleic acid products used in the analysis of nucleic acids, e.g. primers or probes for diseases caused by alterations of genetic material
- C12Q1/6886—Nucleic acid products used in the analysis of nucleic acids, e.g. primers or probes for diseases caused by alterations of genetic material for cancer
-
- G—PHYSICS
- G01—MEASURING; TESTING
- G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
- G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
- G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
- G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
- G01N33/53—Immunoassay; Biospecific binding assay; Materials therefor
- G01N33/575—Immunoassay; Biospecific binding assay; Materials therefor for cancer
-
- G—PHYSICS
- G01—MEASURING; TESTING
- G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
- G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
- G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
- G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
- G01N33/53—Immunoassay; Biospecific binding assay; Materials therefor
- G01N33/575—Immunoassay; Biospecific binding assay; Materials therefor for cancer
- G01N33/57557—Immunoassay; Biospecific binding assay; Materials therefor for cancer of other specific parts of the body, e.g. brain
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12Q—MEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
- C12Q2600/00—Oligonucleotides characterized by their use
- C12Q2600/158—Expression markers
Landscapes
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Engineering & Computer Science (AREA)
- Immunology (AREA)
- Molecular Biology (AREA)
- Biomedical Technology (AREA)
- Hematology (AREA)
- Urology & Nephrology (AREA)
- Pathology (AREA)
- Analytical Chemistry (AREA)
- Biochemistry (AREA)
- Physics & Mathematics (AREA)
- Microbiology (AREA)
- General Health & Medical Sciences (AREA)
- Biotechnology (AREA)
- Food Science & Technology (AREA)
- Medicinal Chemistry (AREA)
- Cell Biology (AREA)
- General Physics & Mathematics (AREA)
- Organic Chemistry (AREA)
- Proteomics, Peptides & Aminoacids (AREA)
- Genetics & Genomics (AREA)
- Wood Science & Technology (AREA)
- Zoology (AREA)
- Oncology (AREA)
- Biophysics (AREA)
- Hospice & Palliative Care (AREA)
- Bioinformatics & Cheminformatics (AREA)
- General Engineering & Computer Science (AREA)
- Measuring Or Testing Involving Enzymes Or Micro-Organisms (AREA)
- Investigating Or Analysing Biological Materials (AREA)
- Immobilizing And Processing Of Enzymes And Microorganisms (AREA)
Applications Claiming Priority (4)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| JP9405196 | 1996-04-16 | ||
| JP9405096 | 1996-04-16 | ||
| JP9542796 | 1996-04-17 | ||
| PCT/JP1997/001300 WO1997039354A1 (en) | 1996-04-16 | 1997-04-15 | Method of detecting solid cancer cells and histological heterotypia and method of examining tissue for bone marrow transplantation and peripheral blood stem cell transplantation |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| ATE298887T1 true ATE298887T1 (de) | 2005-07-15 |
Family
ID=27307463
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| AT97915725T ATE298887T1 (de) | 1996-04-16 | 1997-04-15 | Verfahren zum nachweis solider krebszellen und histologischer heterotypien und verfahren zur prüfung von gewebe für die knochenmarktransplantation und die transplantation von peripheren blutstammzellen |
Country Status (10)
| Country | Link |
|---|---|
| US (1) | US6225051B1 (de) |
| EP (1) | EP0846949B1 (de) |
| JP (1) | JP3122771B2 (de) |
| KR (1) | KR100262838B1 (de) |
| AT (1) | ATE298887T1 (de) |
| CA (1) | CA2224970C (de) |
| DE (1) | DE69733629T2 (de) |
| ES (1) | ES2242221T3 (de) |
| TW (1) | TW562928B (de) |
| WO (1) | WO1997039354A1 (de) |
Families Citing this family (62)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| JP4789095B2 (ja) * | 1997-07-16 | 2011-10-05 | 治夫 杉山 | ウイルムス腫瘍遺伝子（ｗｔ１）に対する発現阻害物質を含んで成る固形腫瘍治療剤 |
| US6392257B1 (en) | 2000-02-10 | 2002-05-21 | Motorola Inc. | Semiconductor structure, semiconductor device, communicating device, integrated circuit, and process for fabricating the same |
| US6693033B2 (en) | 2000-02-10 | 2004-02-17 | Motorola, Inc. | Method of removing an amorphous oxide from a monocrystalline surface |
| AU2001249548A1 (en) * | 2000-03-27 | 2001-10-08 | Thomas Jefferson University | Compositions and methods for identifying and targeting cancer cells |
| JP3846199B2 (ja) | 2000-05-24 | 2006-11-15 | 治夫 杉山 | Ｗｔ１関連疾患の検査方法 |
| KR20030011083A (ko) | 2000-05-31 | 2003-02-06 | 모토로라 인코포레이티드 | 반도체 디바이스 및 이를 제조하기 위한 방법 |
| AU2001264987A1 (en) * | 2000-06-30 | 2002-01-14 | Motorola, Inc., A Corporation Of The State Of Delware | Hybrid semiconductor structure and device |
| US6555946B1 (en) | 2000-07-24 | 2003-04-29 | Motorola, Inc. | Acoustic wave device and process for forming the same |
| WO2002009187A2 (en) | 2000-07-24 | 2002-01-31 | Motorola, Inc. | Heterojunction tunneling diodes and process for fabricating same |
| US6638838B1 (en) | 2000-10-02 | 2003-10-28 | Motorola, Inc. | Semiconductor structure including a partially annealed layer and method of forming the same |
| US20020096683A1 (en) | 2001-01-19 | 2002-07-25 | Motorola, Inc. | Structure and method for fabricating GaN devices utilizing the formation of a compliant substrate |
| US6673646B2 (en) | 2001-02-28 | 2004-01-06 | Motorola, Inc. | Growth of compound semiconductor structures on patterned oxide films and process for fabricating same |
| WO2002082551A1 (en) | 2001-04-02 | 2002-10-17 | Motorola, Inc. | A semiconductor structure exhibiting reduced leakage current |
| US6709989B2 (en) | 2001-06-21 | 2004-03-23 | Motorola, Inc. | Method for fabricating a semiconductor structure including a metal oxide interface with silicon |
| US6992321B2 (en) | 2001-07-13 | 2006-01-31 | Motorola, Inc. | Structure and method for fabricating semiconductor structures and devices utilizing piezoelectric materials |
| US6531740B2 (en) | 2001-07-17 | 2003-03-11 | Motorola, Inc. | Integrated impedance matching and stability network |
| US6646293B2 (en) | 2001-07-18 | 2003-11-11 | Motorola, Inc. | Structure for fabricating high electron mobility transistors utilizing the formation of complaint substrates |
| US7019332B2 (en) | 2001-07-20 | 2006-03-28 | Freescale Semiconductor, Inc. | Fabrication of a wavelength locker within a semiconductor structure |
| US6693298B2 (en) | 2001-07-20 | 2004-02-17 | Motorola, Inc. | Structure and method for fabricating epitaxial semiconductor on insulator (SOI) structures and devices utilizing the formation of a compliant substrate for materials used to form same |
| US6855992B2 (en) | 2001-07-24 | 2005-02-15 | Motorola Inc. | Structure and method for fabricating configurable transistor devices utilizing the formation of a compliant substrate for materials used to form the same |
| US6667196B2 (en) | 2001-07-25 | 2003-12-23 | Motorola, Inc. | Method for real-time monitoring and controlling perovskite oxide film growth and semiconductor structure formed using the method |
| US6589856B2 (en) | 2001-08-06 | 2003-07-08 | Motorola, Inc. | Method and apparatus for controlling anti-phase domains in semiconductor structures and devices |
| US6639249B2 (en) | 2001-08-06 | 2003-10-28 | Motorola, Inc. | Structure and method for fabrication for a solid-state lighting device |
| US20030034491A1 (en) | 2001-08-14 | 2003-02-20 | Motorola, Inc. | Structure and method for fabricating semiconductor structures and devices for detecting an object |
| US6673667B2 (en) | 2001-08-15 | 2004-01-06 | Motorola, Inc. | Method for manufacturing a substantially integral monolithic apparatus including a plurality of semiconductor materials |
| WO2003020899A2 (en) * | 2001-08-31 | 2003-03-13 | Diadexus, Inc. | Compositions and methods relating to lung specific genes and proteins |
| US20030071327A1 (en) | 2001-10-17 | 2003-04-17 | Motorola, Inc. | Method and apparatus utilizing monocrystalline insulator |
| CA2471967A1 (en) * | 2002-01-03 | 2003-07-31 | Board Of Regents, The University Of Texas System | Wt1 antisense oligos for the inhibition of breast cancer |
| US6916717B2 (en) | 2002-05-03 | 2005-07-12 | Motorola, Inc. | Method for growing a monocrystalline oxide layer and for fabricating a semiconductor device on a monocrystalline substrate |
| US7169619B2 (en) | 2002-11-19 | 2007-01-30 | Freescale Semiconductor, Inc. | Method for fabricating semiconductor structures on vicinal substrates using a low temperature, low pressure, alkaline earth metal-rich process |
| US6885065B2 (en) | 2002-11-20 | 2005-04-26 | Freescale Semiconductor, Inc. | Ferromagnetic semiconductor structure and method for forming the same |
| US7020374B2 (en) | 2003-02-03 | 2006-03-28 | Freescale Semiconductor, Inc. | Optical waveguide structure and method for fabricating the same |
| US6965128B2 (en) | 2003-02-03 | 2005-11-15 | Freescale Semiconductor, Inc. | Structure and method for fabricating semiconductor microresonator devices |
| KR101431312B1 (ko) * | 2003-06-27 | 2014-08-20 | 인터내셔널 인스티튜트 오브 캔서 이무놀로지 인코퍼레이티드 | Ｗｔ1 백신 적응 환자의 선택 방법 |
| JP4762133B2 (ja) * | 2004-03-29 | 2011-08-31 | 治夫 杉山 | Ｗｔ１遺伝子の発現を抑制するマイクロｒｎａおよびその利用 |
| WO2005092394A1 (ja) * | 2004-03-29 | 2005-10-06 | Haruo Sugiyama | WT1遺伝子の発現を抑制するsiRNAおよびその利用 |
| EP1657250A1 (de) * | 2004-11-11 | 2006-05-17 | Charité - Universitätsmedizin Berlin | HLA-A*01 bindendes T-Zell-Epitop von WT1 |
| JP5405110B2 (ja) | 2005-09-19 | 2014-02-05 | ベリデックス・エルエルシー | 原発不明がんの原発巣を同定するための方法および材料 |
| US8338109B2 (en) | 2006-11-02 | 2012-12-25 | Mayo Foundation For Medical Education And Research | Predicting cancer outcome |
| EP3173480A3 (de) | 2007-03-05 | 2017-08-16 | International Institute of Cancer Immunology, Inc. | Krebs-antigen-spezifisches t-zell-rezeptorgen, durch das gen codiertes peptid und verwendung davon |
| EP2806054A1 (de) | 2008-05-28 | 2014-11-26 | Genomedx Biosciences Inc. | Systeme und Verfahren zur expressionsbasierten Unterscheidung verschiedener klinischer Krankheitszustände bei Prostatakrebs |
| US10407731B2 (en) | 2008-05-30 | 2019-09-10 | Mayo Foundation For Medical Education And Research | Biomarker panels for predicting prostate cancer outcomes |
| US9495515B1 (en) | 2009-12-09 | 2016-11-15 | Veracyte, Inc. | Algorithms for disease diagnostics |
| US10236078B2 (en) | 2008-11-17 | 2019-03-19 | Veracyte, Inc. | Methods for processing or analyzing a sample of thyroid tissue |
| US9074258B2 (en) | 2009-03-04 | 2015-07-07 | Genomedx Biosciences Inc. | Compositions and methods for classifying thyroid nodule disease |
| US8669057B2 (en) | 2009-05-07 | 2014-03-11 | Veracyte, Inc. | Methods and compositions for diagnosis of thyroid conditions |
| US10446272B2 (en) | 2009-12-09 | 2019-10-15 | Veracyte, Inc. | Methods and compositions for classification of samples |
| US20130267443A1 (en) | 2010-11-19 | 2013-10-10 | The Regents Of The University Of Michigan | ncRNA AND USES THEREOF |
| KR20140033029A (ko) | 2011-04-01 | 2014-03-17 | 메모리얼 슬로안-케터링 캔서 센터 | 에이치엘에이 에이2에 의해 제공된 더블유티1 펩타이드에 특이적인 티 세포 수용체 유사 항체 |
| KR20140039318A (ko) | 2011-06-28 | 2014-04-01 | 인터내셔널 인스티튜트 오브 캔서 이무놀로지 인코퍼레이티드 | 펩티드 암 항원 특이적 ｔ 세포의 리셉터 유전자 |
| EP2791359B1 (de) | 2011-12-13 | 2020-01-15 | Decipher Biosciences, Inc. | Krebsdiagnostik mit nichtcodierenden transkripten |
| DK3435084T3 (da) | 2012-08-16 | 2023-05-30 | Mayo Found Medical Education & Res | Prostatakræftprognose under anvendelse af biomarkører |
| EP3626308A1 (de) | 2013-03-14 | 2020-03-25 | Veracyte, Inc. | Verfahren zur bewertung eines copd-status |
| US11976329B2 (en) | 2013-03-15 | 2024-05-07 | Veracyte, Inc. | Methods and systems for detecting usual interstitial pneumonia |
| US12297505B2 (en) | 2014-07-14 | 2025-05-13 | Veracyte, Inc. | Algorithms for disease diagnostics |
| EP3215170A4 (de) | 2014-11-05 | 2018-04-25 | Veracyte, Inc. | Systeme und verfahren zur diagnose von idiopathischer pulmonaler fibrose auf transbronchialen biopsien mit maschinellem lernen und hochdimensionalen transkriptionsdaten |
| EP3504348B1 (de) | 2016-08-24 | 2022-12-14 | Decipher Biosciences, Inc. | Verwendung von genomischen signaturen zur vorhersage des ansprechens von patienten mit prostatakrebs auf postoperative strahlentherapie |
| EP3571322B9 (de) | 2017-01-20 | 2023-10-04 | VERACYTE SD, Inc. | Molekulare untertypisierung, prognose und behandlung von blasenkrebs |
| EP3593140A4 (de) | 2017-03-09 | 2021-01-06 | Decipher Biosciences, Inc. | Subtypisierung von prostatakrebs zur vorhersage der reaktion auf eine hormontherapie |
| CA3062716A1 (en) | 2017-05-12 | 2018-11-15 | Decipher Biosciences, Inc. | Genetic signatures to predict prostate cancer metastasis and identify tumor agressiveness |
| US11217329B1 (en) | 2017-06-23 | 2022-01-04 | Veracyte, Inc. | Methods and systems for determining biological sample integrity |
| WO2019028285A2 (en) | 2017-08-04 | 2019-02-07 | Genomedx, Inc. | USE OF SPECIFIC GENE EXPRESSION OF IMMUNE CELLS FOR THE PROGNOSIS OF PROSTATE CANCER AND THE PREDICTION OF SENSITIVITY TO RADIOTHERAPY |
Family Cites Families (1)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US5622835A (en) * | 1994-04-28 | 1997-04-22 | The Wistar Institute Of Anatomy & Biology | WT1 monoclonal antibodies |
-
1997
- 1997-04-15 AT AT97915725T patent/ATE298887T1/de not_active IP Right Cessation
- 1997-04-15 JP JP09536949A patent/JP3122771B2/ja not_active Expired - Lifetime
- 1997-04-15 DE DE69733629T patent/DE69733629T2/de not_active Expired - Lifetime
- 1997-04-15 ES ES97915725T patent/ES2242221T3/es not_active Expired - Lifetime
- 1997-04-15 KR KR1019970709409A patent/KR100262838B1/ko not_active Expired - Lifetime
- 1997-04-15 WO PCT/JP1997/001300 patent/WO1997039354A1/ja not_active Ceased
- 1997-04-15 CA CA002224970A patent/CA2224970C/en not_active Expired - Lifetime
- 1997-04-15 US US08/973,967 patent/US6225051B1/en not_active Expired - Lifetime
- 1997-04-15 EP EP97915725A patent/EP0846949B1/de not_active Expired - Lifetime
- 1997-04-16 TW TW086104912A patent/TW562928B/zh not_active IP Right Cessation
Also Published As
| Publication number | Publication date |
|---|---|
| KR100262838B1 (ko) | 2003-03-15 |
| CA2224970C (en) | 2002-04-02 |
| EP0846949A4 (de) | 2002-11-13 |
| ES2242221T3 (es) | 2005-11-01 |
| TW562928B (en) | 2003-11-21 |
| EP0846949B1 (de) | 2005-06-29 |
| JP3122771B2 (ja) | 2001-01-09 |
| US6225051B1 (en) | 2001-05-01 |
| DE69733629D1 (de) | 2005-08-04 |
| DE69733629T2 (de) | 2006-05-18 |
| WO1997039354A1 (en) | 1997-10-23 |
| KR19990022939A (ko) | 1999-03-25 |
| CA2224970A1 (en) | 1997-10-23 |
| EP0846949A1 (de) | 1998-06-10 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| ATE298887T1 (de) | Verfahren zum nachweis solider krebszellen und histologischer heterotypien und verfahren zur prüfung von gewebe für die knochenmarktransplantation und die transplantation von peripheren blutstammzellen | |
| NZ333830A (en) | Method for assessing chemosensitivity of a biopsy sample | |
| ATE333517T1 (de) | Verfahren und sondenset zur erkennung von krebs | |
| ATE326699T1 (de) | Annexin-proteine und auto-antikörper als serummarker für lungenkrebs und ösophaguskrebs | |
| DK221090A (da) | Fremgangsmaade og apparat til diagnostisk analyse ved stroemmaaling | |
| ATE393912T1 (de) | Microarrays und ihre verwendungen | |
| ATE354674T1 (de) | Verfahren zur erkennung von transplantabstossungen | |
| ATE307902T1 (de) | Methoden und testsätze zur probennahme und aufbewahrung von biologischen proben | |
| GB2374872A (en) | Human genome-derived single exon nucleic acid probes useful for analysis of gene expression in human bone marrow | |
| DE69935440D1 (de) | Gerät zum sammeln biologischer proben und gebrauchsverfahren | |
| DE69824004D1 (de) | Verfahren zur quantitativen bestimmung der genexpression mit hilfe der multiplexen competitiven reversen-transkriptase polymerase kettenreaktion | |
| DE69629292D1 (de) | Verfahren zum feststellen der preparationsgüte von objektträgern und proben | |
| AP9801360A0 (en) | Compositions and methods ofr determining anti-viral drug susceptibility and resistance and anti-viral drug screening. | |
| ATE232559T1 (de) | Verfahren zur signalverstärkung | |
| DE60312513D1 (de) | Zusammensetzungen und verfahren zum nachweis vom apo-b48 und apo-b100 | |
| DE59914830D1 (de) | Verfahren und testbesteck zur beurteilung der oxid messung ihrer antiradikalen aktivität | |
| ATE243532T1 (de) | Verfahren zur bewertung von chemotherapeutischen mitteln in vivo | |
| NZ576360A (en) | Marker genes for use in the identification of chondrocyte phenotypic stability and in the screening of factors influencing cartilage production | |
| ATE258310T1 (de) | Testverfahren für collagenpeptid | |
| ATE222122T1 (de) | Verfahren zur tötung von zielzellen in geernteten zellpopulationen mit hilfe von zwei immunotoxinen | |
| SE9403833D0 (sv) | Analysförfarande och kit | |
| BR9808219A (pt) | Processos de identificação e de isolamento de glóbulos vermelhos fetais ou embriÈnicos e de determinação de uma anormalidade fetal, kit de partes para determinação de uma anormalidade fetal e uso de uma unidade de ligação e de um meio | |
| EP1304377A4 (de) | Verfahren zum Nachweis von Krebs | |
| DE60230988D1 (de) | Proteine in der diabetes-proteomanalyse | |
| FR2786787B1 (fr) | Methode d'analyse in vitro d'un phenotype connu a partir d'un echantillon d'acides nucleiques |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| RER | Ceased as to paragraph 5 lit. 3 law introducing patent treaties |